KRISTEN RIDER: Open Payments
NPI 1245726710 · FESTUS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,533 in 72 payments from 26 companies in 2025. Trend: 2023 $2,534 · 2024 $3,040 · 2025 $1,533
Food & beverage: $1,533
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $192 |
| Mannkind Corporation | 7 | $177 |
| Medtronic, Inc. | 3 | $145 |
| Xeris Pharmaceuticals, Inc. | 5 | $87 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $71 |
| Corcept Therapeutics | 3 | $69 |
| ABBVIE INC. | 3 | $68 |
| Sequel Med Tech, LLC | 3 | $67 |
| BETA BIONICS, INC. | 3 | $61 |
Products named: AFREZZA, Ozempic, MINIMED 780G, LEQVIO, ISTURISA, Korlym, TWIIST, iLet Bionic Pancreas.
Industry payments across MO — which companies pay providers there.
